Approved Supply Chain Financing definition

Approved Supply Chain Financing means each Supply Chain Financing offered by a Customer of any Company and in which such Customer has requested that such Company participate: (x) which has been approved in writing by Agent (acting in its Permitted Discretion) as to the applicable Customer, the applicable bank or other financial institution, and the terms of such Supply Chain Financing and (y) in the case of any such Approved Supply Chain Financing that will involve any Disposition of Receivables by any Loan Party, with respect to which Agent and the applicable bank or other financial institution shall have entered into a Supply Chain Lien Agreement acceptable to Agent in its Permitted Discretion.
Sample 1Sample 2
Approved Supply Chain Financing means each Supply Chain Financing offered by a Customer of any Company and in which such Customer has requested that such Company participate: (x) which has been approved in writing by Agent (acting reasonably) as to the applicable Customer, the applicable bank or other financial institution, and the terms of such Supply Chain Financing and (y) in the case of any such Approved Supply Chain Financing that will involve any Disposition of Receivables by any Loan Party, with respect to which Agent, PNC and the applicable bank or other financial institution shall have entered into a Supply Chain Lien Agreement reasonably acceptable to Agent. “Availability” shall mean “Availability” as defined in the ABL Facility Agreement as in effect on the Closing Date. “Available Amount” shall mean, as of any date of determination, the amount equal to: (a) the sum of (without duplication): (i) $105,000,000 plus (ii) the Net Cash Proceeds of any issuances of Equity Interests (other than Disqualified Equity Interests and Specified Equity Contributions) by Parent made after the Closing Date plus (iii) the Net Cash Proceeds of any issuances of Permitted Indebtedness pursuant to clause (h) of the definition of that term made after the Closing Date, minus (b) the sum of (without duplication): (i) all Permitted Acquisitions made after the Closing Date but prior to such date of determination under and/or in reliance on clause (d) of the definition of such term, (ii) all Permitted Investments made after the Closing Date but prior to such date of determination under and/or in reliance on clause (e) of the definition of Permitted Intercompany Advances and clause (g) of the definition of Permitted Investments, and (e) all Permitted Investments made after the Closing Date but prior to such date of determination under and/or in reliance on clause (j) of the definition of Permitted Investments (provided that, to avoid any “double counting”, the amount of any Permitted Acquisition made by any Non-Loan Party under/in reliance on clause (d) of the definition of such term or any Permitted Investment made by any Non-Loan Party under/in reliance on clause (j) of such term shall be deemed, for purposes of the calculation of the Available Amount, to be net of the amount of any proceeds of any Permitted Intercompany Advance that is made under and/or in reliance on clause (e) of such term
Sample 1
Approved Supply Chain Financing means each Supply Chain Financing offered by a Customer of any Company and in which such Customer has requested that such Company participate: (x) which has been approved in writing by Agent (acting reasonably) as to the applicable Customer, the applicable bank or other financial institution, and the terms of such Supply Chain Financing and (y) in the case of any such Approved Supply Chain Financing that will involve any Disposition of Receivables by any Loan Party, with respect to which Agent, PNC and the applicable bank or other financial institution shall have entered into a Supply Chain Lien Agreement reasonably acceptable to Agent.
Sample 1

Related to Approved Supply Chain Financing

  • Collateral Management Agreement The agreement dated as of the Closing Date, between the Issuer and the Collateral Manager relating to the management of the Collateral Obligations and the other Assets by the Collateral Manager on behalf of the Issuer, as amended from time to time in accordance with the terms thereof.

  • Cannabis processing facility means a person that:

  • Securitization Financing means any transaction or series of transactions that may be entered into by the Borrower or any of its Subsidiaries pursuant to which the Borrower or any of its Subsidiaries may sell, convey or otherwise transfer to (a) a Securitization Subsidiary (in the case of a transfer by the Borrower or any of its Subsidiaries) or (b) any other Person (in the case of a transfer by a Securitization Subsidiary), or may grant a security interest in, any Securitization Assets of the Borrower or any of its Subsidiaries, and any assets related thereto, including all collateral securing such Securitization Assets, all contracts and all guarantees or other obligations in respect of such Securitization Assets, proceeds of such Securitization Assets and other assets that are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving Securitization Assets.

  • Permitted Securitization Financing means one or more transactions pursuant to which (i) Securitization Assets or interests therein are sold to or financed by one or more Special Purpose Securitization Subsidiaries, and (ii) such Special Purpose Securitization Subsidiaries finance their acquisition of such Securitization Assets or interests therein, or the financing thereof, by selling or borrowing against Securitization Assets and any Hedging Agreements entered into in connection with such Securitization Assets; provided, that recourse to the Borrower or any Subsidiary (other than the Special Purpose Securitization Subsidiaries) in connection with such transactions shall be limited to the extent customary (as determined by the Borrower in good faith in consultation with the Administrative Agent) for similar transactions in the applicable jurisdictions (including, to the extent applicable, in a manner consistent with the delivery of a “true sale”/“absolute transfer” opinion with respect to any transfer by the Borrower or any Subsidiary (other than a Special Purpose Securitization Subsidiary)).

  • Secondary dose monitoring system means a system which will terminate irradiation in the event of failure of the primary dose monitoring system.

  • Project Management Agreement means the agreement dated the 20th February 1985 made between the Trustee and the Manager providing for the Manager to manage and co-ordinate the development and construction of the Resort and includes, if that agreement is terminated, any other agreement in like and similar terms made with the prior consent of the Minister;

  • Performing First Lien Bank Loans means First Lien Bank Loans which are Performing.

  • Investment Management Agreement means the Investment Management Agreement, dated as of the date hereof, by and between the Investment Manager and the Borrower.

  • Project financing gap means the part of the total project cost,

  • Secured Treasury Management Agreement means any Treasury Management Agreement between any Loan Party and any Treasury Management Bank; provided, that for any of the foregoing to be included as a “Secured Treasury Management Agreement” on any date of determination by the Administrative Agent, the applicable Treasury Management Bank (other than the Administrative Agent or an Affiliate of the Administrative Agent) must have delivered a Secured Party Designation Notice to the Administrative Agent prior to such date of determination.

  • Asset Management Agreement means, as the context requires, any agreement entered into between a Series and an Asset Manager pursuant to which such Asset Manager is appointed as manager of the relevant Series Assets, as amended from time to time.

  • Medical marijuana concentrate means a specific subset of Medical Marijuana that was produced by extracting cannabinoids from Medical Marijuana. Categories of Medical Marijuana Concentrate include Water-Based Medical Marijuana Concentrate, Food-Based Medical Marijuana Concentrate and Solvent-Based Medical Marijuana Concentrate.

  • Collateral Management Fee The fee payable to the Collateral Manager in arrears on each Payment Date pursuant to Section 8(a) of the Collateral Management Agreement and Section 11.1 hereof, comprised of (x) the Base Management Fee and (y) the Subordinated Management Fee.

  • Collateral Acquisition Agreements means each of the agreements entered into by the Issuer in relation to the purchase by the Issuer of Collateral Debt Obligations from time to time.

  • Replacement Management Agreement means, collectively, (a) either (i) a management agreement with a Qualified Manager substantially in the same form and substance as the Management Agreement, or (ii) a management agreement with a Qualified Manager, which management agreement shall be reasonably acceptable to Lender in form and substance, provided, with respect to this subclause (ii), Lender, at its option, may require that Borrower shall have obtained prior written confirmation from the applicable Rating Agencies that such management agreement will not cause a downgrade, withdrawal or qualification of the then current rating of the Securities or any class thereof and (b) an assignment of management agreement and subordination of management fees substantially in the form then used by Lender (or of such other form and substance reasonably acceptable to Lender), executed and delivered to Lender by Borrower and such Qualified Manager at Borrower’s expense.

  • Hotel Management Agreement means any management agreement or operating agreement pursuant to which a Hotel Operator manages the operations of a Hotel Asset.

  • Procurement Management means the Director of Lee County’s Procurement Management Department or designee.

  • Grenfell Tower support payment means a payment made to a person because that person was affected by the fire on 14th June 2017 at Grenfell Tower, or a payment to the personal representative of such a person—

  • Designated Senior Representative means (i) if at any time there is only one Senior Representative for a Senior Facility with respect to which the Discharge of Senior Obligations has not occurred, such Senior Representative and (ii) at any time when clause (i) does not apply, the Applicable Authorized Representative (as defined in the First Lien Intercreditor Agreement) at such time.

  • Medical equipment supplier means any person, as defined in § 1-230, engaged in the delivery to

  • LOCKHEED MARTIN Procurement Representative means a person authorized by LOCKHEED MARTIN's cognizant procurement organization to administer and/or execute this Contract.

  • Real estate-related financial transaction means any transaction involving:

  • Permanent Supportive Housing means voluntary, flexible supports to help individuals with psychiatric disabilities choose, get, and keep housing that is decent, safe, affordable, and integrated into the community. Tenants have access to an array of services that help them keep their housing, such as case management, assistance with daily activities, conflict resolution, and crisis response consistent with evidence-based practice standards published by the Substance Abuse and Mental Health Services Administration.

  • Contractor-acquired property means property acquired, fabricated, or otherwise provided by the Contractor for performing a contract, and to which the Government has title.

  • Permitted Financing means (i) the Company’s issuance of Common Stock and warrants therefore in connection with a merger and/or acquisition or consolidation, (ii) the issuance of shares of Common Stock or warrants therefore in connection with strategic license agreements so long as such issuances are not for the purpose of raising capital, (iii) the Company’s issuance of Common Stock or the issuance or grants of options to purchase Common Stock pursuant to the Company’s stock option plans and employee stock purchase plans as they now exist, and (iv) the issuance of Common Stock upon the exercise or conversion of any securities outstanding on the date hereof.

  • Drug therapy management means the review of a drug therapy regimen of a patient by one or more pharmacists for the purpose of evaluating and rendering advice to one or more practitioners regarding adjustment of the regimen.